Prosecution Insights
Last updated: August 17, 2026

Examiner: POPA, ILEANA

Tech Center 1600 • Art Units: 1600 1633 1663

This examiner grants 21% of resolved cases

Performance Statistics

21.4%
Allow Rate
-38.6% vs TC avg
895
Total Applications
+14.6%
Interview Lift
1720
Avg Prosecution Days
Based on 835 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
7.7%
§102 Novelty
48.1%
§103 Obviousness
21.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18088544 POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY Final Rejection University of Massachusetts
16623268 MATERIALS AND METHODS FOR INCREASING IMMUNE RESPONSES Final Rejection Mayo Foundation for Medical Education and Research
17918887 ENHANCING AAV-MEDIATED DELIVERY AND TRANSDUCTION WITH POLYVINYL ALCOHOL Non-Final OA University of Florida Research Foundation, Incorporated
18471761 DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION Final Rejection Board of Regents of The University of Texas System
18022415 METHOD FOR IN VITRO PRODUCTION OF RED BLOOD CELLS Final Rejection IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY)

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month